We aim to make the transfer of knowledge more flexible and effective via interactive, engaging training solutions.
On Demand eLearning
Visual Training Aids
Nurturing professional growth
We work with you to identify knowledge gaps to develop cohesive training solutions
Our expertise in pricing, health economics and market access coupled with our in-house creative instructional design team, allows us to create and deploy bespoke training solutions specific to your needs and product pipeline
We also have an extensive range of off-the-shelf training modules from foundation to advanced market access learning
We help your organization to understand market access and what it really means for your commercial success.
The market access training module typically provides an understanding of:
Pricing and market access principles
The importance of payers and Health Technology Assessments (HTA), incorporating current trends in HTA and payer evaluation criteria
Overview of country healthcare systems, including the approaches used to price and reimburse pharmaceuticals
Health technology assessment
We will enable learners to understand the concept of how HTA may be used to determine the price.
We will enable learners to understand the concept of how HTA may be used to determine the price, reimbursement and/or access of a new pharmaceutical product:
What is a HTA?
Different types of HTAs globally
The HTA process
Components of an HTA submission
How to address HTA uncertainties
Optimizing the quality of evidence
Using real-life case studies, our HTA training program provides insights into what your organization should do to optimize HTA outcomes for your products
Our health economics training provides learners with an understanding of the terminology and methodologies used.
Having a detailed understanding of the principles of health economic evaluation and how health economics is used by payers to determine if your product is cost-effective is essential to enable patient access
Our health economics training provides learners with an understanding of the terminology and methodologies used within health economic analysis (e.g. what is an ICER and what is a QALY) and its importance within health technology assessments
More advanced topics covered include health economic model designs, managing uncertainty within models and incorporating health economics into the product lifecycle, to help ensure positive outcomes
Developing, communicating and capturing payer value are critical during the pricing of pharmaceutical products.
Pharmaceutical pricing strategy is more than simply setting the price of a product in order to recover Research and Development (R&D) investments
Developing, communicating and capturing payer value are critical during the pricing of pharmaceutical products
Our pharmaceutical pricing training covers essential topics, such as value based pricing approaches, global pricing strategies, pricing terminology and relationship between price, volume and revenue optimization
Country healthcare systems
Understanding the pricing and reimbursement processes and stakeholder needs at a country level.
Understanding the pricing and reimbursement processes and stakeholder needs at a country level can facilitate market access strategy development at a local and global level
Payer negotiation tactics
Learn how to approach pricing and reimbursement discussions with payers to facilitate negotiations.
Learn how to approach pricing and reimbursement discussions with payers to facilitate negotiations
Managed entry agreements
Understand how managed entry agreements (MEAs) can be used to facilitate patient access.
Understand how managed entry agreements (MEAs) can be used to facilitate patient access. The training also highlights the pros and cons of different approaches and how to implement MEAs at a local level
Real world evidence (RWE) is increasingly playing an important role in developing product value propositions.
Our real-world evidence training explores the fundamental principles of real world evidence for market access. This includes defining the differences between real world evidence and real-world data and understanding the benefits, limitations and current trends of using real-world evidence.
You will gain an understanding into why payers, physicians and pharma need real world evidence and how to communicate real world evidence to each stakeholder. We will consider challenges in undertaking real world evidence analysis in practice and provide you with insight into how to incorporate real world evidence into your commercial decisions.
I really enjoyed working with Remap Consulting and received powerful advice. A small company like ours needs to receive a flexible approach in order start with market access activities, and I am very happy to see you are as flexible as possible with us.
Director of Market Access
Small pharma payer insights for clinical trials
Remap Consulting’s pricing knowledge and support has been critical to the success of our new pricing team. Their combined experience has provided them with ‘real-world‘ knowledge that can support their recommendations. I highly recommend Remap Consulting and am delighted to continue my work with their pricing group.
Senior Director, Head of Global Pricing
Outsourcing pricing activities for large biotech
Stay in the know, subscribe to our newsletter
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Talk to an expert
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.